
Afanat 40 Tablet
Marketer
Natco Pharma Ltd
Salt Composition
Afatinib dimaleate (40mg)
Overview Afanat 40 Tablet
Erlotinib 40mg tablets are indicated for treating non-small cell lung cancer in adults with specific epidermal growth factor receptor (EGFR) gene mutations. Optimal absorption requires administration on an empty stomach, consistently at the same time each day. Dosage and frequency are determined by your physician based on your individual needs and may be adjusted. Strict adherence to your doctor's prescribed regimen is crucial, as incorrect usage or overdose can lead to severe adverse reactions. While therapeutic effects might not be immediately apparent, lasting several weeks or months, discontinuation should only occur under medical supervision. Common side effects encompass nausea, diarrhea (which may require specific medical management and hydration), rash, and dry skin. Regular blood monitoring may be advised, and sun sensitivity necessitates sunscreen and protective clothing. Report any ocular irritation (pain, redness, dryness) to your doctor. Prior to commencing treatment, disclose any pre-existing respiratory, hepatic, or renal conditions, and all concurrent medications, including anti-infectives, as drug interactions are possible. This medication is contraindicated during pregnancy and lactation; effective contraception is essential for women undergoing treatment.
Uses of Afanat 40 Tablet
Lung cancer (excluding small cell type)
Major Benefits of Afanat 40 Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Afanat 40 Tablets should be taken on an empty stomach.
Common Side effects of Afanat 40 Tablet:
- Diarrhea
- Rash
- Dry skin
- Nausea
- Vomiting
- Loss of appetite
- Itching
- Stomatitis (Inflammation of the mouth)
- Nail disorder
How to use Afanat 40 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Afanat 40 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication on an empty stomach.
How Afanat 40 Tablet works:
Afanat 40 Tablet combats cancer by targeting and blocking specific enzyme receptors (EGFR, HER2, and HER4) crucial for cancer cell proliferation. This targeted inhibition disrupts crucial signaling pathways, thereby curbing or slowing cancer progression.
SAFETY ADVICE
AlcoholSAFE
Afanat 40 Tablet can be taken with alcohol without adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Using Afanat 40 Tablet during pregnancy poses a confirmed risk to the fetus. Its use should only be considered in exceptional, life-threatening circumstances where the potential benefits clearly outweigh the dangers, as determined by a physician. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Afanat 40 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
Afanat 40 Tablet's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Afanat 40 Tablet is likely safe for individuals with kidney impairment. Available evidence indicates dose modification may be unnecessary, but physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Afanat 40 Tablet is likely safe for individuals with liver conditions. Available evidence indicates dose modification may not be necessary. Physician consultation is recommended.
What if you forget to take Afanat 40 Tablet :
Omit any missed Afanat 40 Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Afanat 40 Tablet
| Label | Value |
|---|---|
| Chemical Type | Quinazoline-Butenamide Hybrid |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Behavior Class | TKIs |
